首页> 外文期刊>WSEAS Transactions on Systems >Automated Trisomy 21 Assessment Based on Maternal Serum Markers Using Trivariate Lognormal Distribution
【24h】

Automated Trisomy 21 Assessment Based on Maternal Serum Markers Using Trivariate Lognormal Distribution

机译:基于三变量对数正态分布的基于孕妇血清标记物的21三体性自动评估

获取原文
获取原文并翻译 | 示例
           

摘要

Trisomy 21 is the most frequent types of chromosomal abnormalities. Generally, current methods for trisomy risk assessment are divided into two techniques, which are invasive and non-invasive methods. Invasive methods are including amniocentesis, chorionic villus sampling (CVS), or percutaneous umbilical cord blood sampling (PUBS), but its drawbacks are expensive, time consuming and having risk of miscarriage, where else non-invasive methods are counting on ultrasound marker and maternal serum markers screening. Nevertheless, single evaluations on ultrasound markers itself are always not enough for risk assessment in terms of its accuracy, reliability and consistency. So, we proposed a new mathematical algorithm which combines three maternal serum markers using trivariate lognormal distribution to calculate automatically the probability or likelihood that a woman has an affected pregnancy or not. The developed algorithm was implemented into graphical user interface to act as computer aided e-diagnostic system. We have compared the results with published finding and found it is almost equally accurate.
机译:21三体是最常见的染色体异常类型。通常,当前的三体风险评估方法分为两种技术,即侵入性和非侵入性方法。侵入性方法包括羊膜穿刺术,绒毛膜绒毛取样(CVS)或经皮脐带血取样(PUBS),但其缺点是昂贵,耗时且有流产的风险,而其他非侵入性方法则依靠超声标记物和产妇血清标志物筛选。然而,就其准确性,可靠性和一致性而言,对超声标记物本身进行单一评估始终不足以进行风险评估。因此,我们提出了一种新的数学算法,该算法结合使用三变量对数正态分布的三个孕产妇血清标志物来自动计算妇女受孕或未受孕的可能性或可​​能性。所开发的算法被实施到图形用户界面中,以用作计算机辅助电子诊断系统。我们将结果与已发表的发现进行了比较,发现它几乎同样准确。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号